ABSTRACT
The Committee for Proprietary Medicinal Products (CPMP) has always attached a great deal of importance to the preparation of guidelines on the quality, safety, and efficacy of medicinal products. The first sets of CPMP guidelines were published as recommendations from the Council of Ministers to the Member States. Two such sets of guidelines were adopted-Council Recommendation 83/ 571/EEC of 26 October 1983, and Council Recommendation 87/176/EEC of 9 February 1987.
